These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 32463093)
41. Passport to freedom? Immunity passports for COVID-19. Brown RCH; Savulescu J; Williams B; Wilkinson D J Med Ethics; 2020 Oct; 46(10):652-659. PubMed ID: 32817362 [TBL] [Abstract][Full Text] [Related]
42. Privileges and Immunity Certification During the COVID-19 Pandemic. Hall MA; Studdert DM JAMA; 2020 Jun; 323(22):2243-2244. PubMed ID: 32374358 [No Abstract] [Full Text] [Related]
43. Testing for COVID-19 at travel clinics in Japan. Ujiie M; Ohmagari N; Inoue H J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32597471 [No Abstract] [Full Text] [Related]
44. Clinical Performance of the Roche SARS-CoV-2 Serologic Assay. Tang MS; Hock KG; Logsdon NM; Hayes JE; Gronowski AM; Anderson NW; Farnsworth CW Clin Chem; 2020 Aug; 66(8):1107-1109. PubMed ID: 32484860 [No Abstract] [Full Text] [Related]
45. Music of microbiota against SARS CoV-2. Belojevic G; Prasher D Noise Health; 2019; 21(100):97. PubMed ID: 32655062 [No Abstract] [Full Text] [Related]
46. Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data. Naaber P; Hunt K; Pesukova J; Haljasmägi L; Rumm P; Peterson P; Hololejenko J; Eero I; Jõgi P; Toompere K; Sepp E PLoS One; 2020; 15(10):e0237548. PubMed ID: 33108380 [TBL] [Abstract][Full Text] [Related]
47. How ADA methodology informs SARS-CoV-2 assay development. Becker C Bioanalysis; 2020 Sep; 12(18):1275-1277. PubMed ID: 32915061 [No Abstract] [Full Text] [Related]
49. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19. Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840 [TBL] [Abstract][Full Text] [Related]
50. Combat COVID-19 with artificial intelligence and big data. Lin L; Hou Z J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32437541 [No Abstract] [Full Text] [Related]
51. Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic? Laxminarayan R; John TJ Indian Pediatr; 2020 Jun; 57(6):505-507. PubMed ID: 32376793 [No Abstract] [Full Text] [Related]
53. Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection? Bi J; Ma H; Zhang D; Huang J; Yang D; Wang Y; Verma V; Zhang T; Hu D; Mei Q; Han G; Li J Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32883679 [TBL] [Abstract][Full Text] [Related]
54. The 2019 human coronavirus: Ten areas of uncertainty waiting to be resolved. Mortimer PP Rev Med Virol; 2020 Jul; 30(4):e2114. PubMed ID: 32394505 [No Abstract] [Full Text] [Related]
55. Re-starting travel in the era of COVID-19: preparing anew. Wilson ME; Chen LH J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32597473 [TBL] [Abstract][Full Text] [Related]
56. COVID-19 in the maritime setting: the challenges, regulations and the international response. Stannard S Int Marit Health; 2020; 71(2):85-90. PubMed ID: 32604450 [No Abstract] [Full Text] [Related]
57. Czech Republic and low COVID-19 mortality in the heart of Europe: possible explanations. Widimsky P; Benes J; Celko AM Eur Heart J; 2020 Oct; 41(40):3876-3879. PubMed ID: 33170931 [No Abstract] [Full Text] [Related]
58. COVID-19: Is there a role for Western blots and skin testing for determining immunity and development of a vaccine? Pavia CS; Wormser GP Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115148. PubMed ID: 32920452 [TBL] [Abstract][Full Text] [Related]
59. COVID-19 lockdown of Roma settlements in Slovakia. Holt E Lancet Infect Dis; 2020 Jun; 20(6):659. PubMed ID: 32473137 [No Abstract] [Full Text] [Related]